ACCOUNTS - Final Accounts preparation

Analysis of the maturity of loans is given below:

Registered number: 12257695

DNA PLUS ANALYSIS LTD

UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2024

DNA PLUS ANALYSIS LTD

REGISTERED NUMBER: 12257695

BALANCE SHEET

AS AT 31 DECEMBER 2024

		2024		2023
Note		£		£


Current assets
Debtors: amounts falling due within one year	4	74,138		70,263
		74,138		70,263
Creditors: amounts falling due within one year	5	(68,162)		(53,693)
Net current assets			5,976		16,570
Total assets less current liabilities			5,976		16,570
Creditors: amounts falling due after more than one year	6		(4,167)		(14,167)

Net assets			1,809		2,403

Capital and reserves
Called up share capital	8	1	1
Profit and loss account		1,808	2,402
		1,809	2,403

Page 1

DNA PLUS ANALYSIS LTD

REGISTERED NUMBER: 12257695

BALANCE SHEET (CONTINUED)

AS AT 31 DECEMBER 2024

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 25 September 2025.

H Hothi

Director

The notes on pages 3 to 8 form part of these financial statements.

Page 2

DNA PLUS ANALYSIS LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

1.	General information

The Company is a private company, limited by shares, incorporated and domiciled in England within the United Kingdom, registration number 12257695. The Company's registered office is Sterling House, 71 Francis Road, Edgbaston, Birmingham, B16 8SP.
The financial statements are presented in sterling which is the functional currency of the company and
the financial statements are rounded to the nearest £1.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

2.2

Going concern

The directors have prepared the accounts on the going concern basis.

Page 3

DNA PLUS ANALYSIS LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:

∙the Company has transferred the significant risks and rewards of ownership to the buyer;

∙the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;

∙the amount of revenue can be measured reliably;

∙it is probable that the Company will receive the consideration due under the transaction; and

∙the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:

∙the amount of revenue can be measured reliably;

∙it is probable that the Company will receive the consideration due under the contract;

∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and

∙the costs incurred and the costs to complete the contract can be measured reliably.

2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

2.6

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

Page 4

DNA PLUS ANALYSIS LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

2.7

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Employees

The average monthly number of employees, including directors, during the year was 1 (2023 - 1).

Debtors

					2024	2023
					£	£


Other debtors	74,138	70,263
	74,138	70,263

Page 5

DNA PLUS ANALYSIS LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

5.	Creditors: Amounts falling due within one year
		2024	2023
		£	£

Bank loans	10,000	10,000
Corporation tax	-	77
Other creditors	57,612	43,066
Accruals and deferred income	550	550
	68,162	53,693

6.	Creditors: Amounts falling due after more than one year
		2024	2023
		£	£

Bank loans	4,167	14,167
	4,167	14,167

Page 6

DNA PLUS ANALYSIS LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

Amounts falling due within one year
Bank loans	10,000	10,000
	10,000	10,000
Amounts falling due 1-2 years
Bank loans	4,167	10,000
	4,167	10,000
Amounts falling due 2-5 years
Bank loans	-	4,167
	-	4,167

	14,167	24,167

8.	Share capital
		2024	2023
		£	£

Allotted, called up and fully paid

1 (2023 - 1) Ordinary share of £1.00	1	1

9.Other financial commitments

As at the balance sheet date the company had total commitments of £12,880 (2023 - £34,960).

Page 7

DNA PLUS ANALYSIS LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

10.

Related party transactions

The director and close family members of the director have made loans to the company. As at 31 December 2024 amounts of £19,358 (2023 - £5,431) were due to the directors and close family. Loans are repayable on demand and interest is charged on overdrawn amounts.
The company has made loans to companies under the common control of the director. As at 31 December 2024 amounts of £571,351 (2023 - £68,096) were due to the company. Loans are interest free and repayable on demand.
The company has received loans from companies under the common control of the director. As at 31 December 2024 amounts of £37,635 (2023 - £37,635) were due from the company. Loans are interest free and repayable on demand.

Page 8